Coya Therapeutics (COYA) Revenue & Revenue Breakdown
Coya Therapeutics Revenue Highlights
Latest Revenue (Y)
$6.00M
Coya Therapeutics Revenue by Period
Coya Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $6.00M | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | - |
Coya Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | -100.00% |
2024-06-30 | $3.43M | 2600.51% |
2024-03-31 | $126.84K | -97.89% |
2023-12-31 | $6.00M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | - |
Coya Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
STRO | Sutro Biopharma | $153.73M | $25.71M |
FENC | Fennec Pharmaceuticals | $21.64M | $6.97M |
TCRX | TScan Therapeutics | $21.05M | - |
CNTA | Centessa Pharmaceuticals | $6.88M | - |
COYA | Coya Therapeutics | $6.00M | - |
CUE | Cue Biopharma | $5.49M | $3.34M |
OPT | Opthea | $108.41K | $61.27K |
GANX | Gain Therapeutics | $55.18K | - |
LTRN | Lantern Pharma | - | - |
CGTX | Cognition Therapeutics | - | - |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
INAB | IN8bio | - | - |
HLVX | HilleVax | - | - |
TERN | Terns Pharmaceuticals | - | - |
DRMA | Dermata Therapeutics | - | - |